A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer.

Greasley, R., Khabazhaitajer, M. and Rosario, D.J. orcid.org/0000-0002-9086-3592 (2015) A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer. Cancer Management and Research, 7. pp. 153-164. ISSN 1179-1322

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2015 Greasley et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
Keywords: MDV3100; androgen receptor; anti-androgen; enzalutamide; metastatic castrate resistant prostate cancer
Dates:
  • Published: 12 June 2015
  • Accepted: 7 September 2014
  • Published (online): 12 June 2015
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 09 Aug 2016 10:17
Last Modified: 09 Aug 2016 10:17
Published Version: http://dx.doi.org/10.2147/CMAR.S50585
Status: Published
Publisher: Dove Medical Press
Refereed: Yes
Identification Number: https://doi.org/10.2147/CMAR.S50585
Related URLs:

Share / Export

Statistics